Difference between revisions of "HAEM5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[unchecked revision] | [unchecked revision] |
Line 171: | Line 171: | ||
| | | | ||
|- | |- | ||
− | |Childhood myelodysplastic neoplasm with increased blasts||Disease||Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | + | |Childhood myelodysplastic neoplasm with increased blasts||Disease|| || || || || ||FQR|| || |
− | + | |Refractory Cytopenia of Childhood | |
− | + | |Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | |
− | | | + | |Complete |
| | | | ||
| | | | ||
|- | |- | ||
− | |Chronic myelomonocytic leukaemia||Disease|| | + | |Chronic myelomonocytic leukaemia||Disease|| || || || || ||FQR|| || |
− | | | + | |Chronic Myelomonocytic Leukemia (CMML) |
− | | | + | |Linsheng Zhang, MD, PhD |
− | | | + | |Complete |
| | | | ||
| | | | ||
|- | |- | ||
− | |Myelodysplastic/myeloproliferative neoplasm with neutrophilia||Disease|| | + | |Myelodysplastic/myeloproliferative neoplasm with neutrophilia||Disease|| || || || || ||FQR|| || |
− | | | + | |Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative |
− | | | + | |Linsheng Zhang, MD, PhD |
− | | | + | |Complete |
| | | | ||
| | | | ||
|- | |- | ||
− | |Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis||Disease||Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | + | |Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis||Disease|| || || || || ||FQR|| || |
− | + | |Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) | |
− | + | |Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | |
− | | | + | |Complete |
− | | | + | |Date page was created |
| | | | ||
|- | |- |
Revision as of 11:50, 18 December 2023
Disease (5th Edition) | Page Type | Author (5th Edition) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Content Status (4th Edition)(Pending or Complete) | Date of Last Editor Review (4th Edition) | Notes (4th Edition) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS) |
|
|
||||||||||||
Clonal haematopoiesis | Disease | Fabiola Quintero-Rivera (FQR) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
Clonal cytopenias of undetermined significance | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
Chronic myeloid leukaemia | Disease | FQR | Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive | Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | Complete | Date page was created | ||||||||
Chronic neutrophilic leukaemia | Disease | FQR | Chronic Neutrophilic Leukemia (CNL) | Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally | Complete | Date page was created | ||||||||
Chronic eosinophilic leukaemia | Disease | FQR | Chronic Eosinophilic Leukemia, Not Otherwise Specified | Chelsea D. Kramish; Daynna J.Wolff | complete/pending faculty review | |||||||||
Polycythaemia vera | Disease | FQR | Polycythemia Vera (PV) | Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center | Complete | |||||||||
Essential thrombocythaemia | Disease | FQR | Essential Thrombocythemia (ET) | Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN | Complete | |||||||||
Primary myelofibrosis | Disease | FQR | Primary Myelofibrosis (PMF) | T. Niroshi Senaratne, UCLA | Complete | 8/4/2020 before submission |
||||||||
Juvenile myelomonocytic leukaemia | Disease | FQR | Juvenile Myelomonocytic Leukemia (JMML) | Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology
Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories |
PENDING importing content and reference formatting | FQR has emailed SR several times, last 4/20/22 | ||||||||
Myeloproliferative neoplasm, NOS | Disease | FQR | Myeloproliferative Neoplasm (MPN), Unclassifiable | Thomas Lee, MD, PhD, University of California, Los Angeles | Complete | |||||||||
Cutaneous mastocytosis | Disease | FQR | Cutaneous Mastocytosis | S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD | Complete | |||||||||
Systemic mastocytosis | Disease | FQR | Systemic Mastocytosis | Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University | Complete | |||||||||
Mast cell sarcoma | Disease | FQR | Mast Cell Sarcoma | Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL | Complete | |||||||||
Myelodysplastic neoplasm with low blasts and 5q deletion | Disease | FQR | Myelodysplastic Syndrome (MDS) with Isolated del(5q) | Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG | Complete | |||||||||
Myelodysplastic neoplasm with low blasts and SF3B1 mutation | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
Myelodysplastic neoplasm with biallelic TP53 inactivation | Disease | Eric McGinnis (assigned to new 5th edition page - FQR please follow-up to confirm) | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||||
Myelodysplastic neoplasm with low blasts | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
Myelodysplastic neoplasm, hypoplastic | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
Myelodysplastic neoplasm with increased blasts | Disease | FQR | Myelodysplastic Syndrome (MDS) with Excess Blasts | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
Childhood myelodysplastic neoplasm with low blasts | Disease | FQR | Refractory Cytopenia of Childhood | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
Childhood myelodysplastic neoplasm with increased blasts | Disease | FQR | Refractory Cytopenia of Childhood | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
Chronic myelomonocytic leukaemia | Disease | FQR | Chronic Myelomonocytic Leukemia (CMML) | Linsheng Zhang, MD, PhD | Complete | |||||||||
Myelodysplastic/myeloproliferative neoplasm with neutrophilia | Disease | FQR | Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative | Linsheng Zhang, MD, PhD | Complete | |||||||||
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | Disease | FQR | Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) | Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | Complete | Date page was created | ||||||||
Myelodysplastic/myeloproliferative neoplasm, NOS | Disease | Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia | FQR | |||||||||||
Myeloid/lymphoid neoplasm with PDGFRA rearrangement | Disease | Jay Alden, DO | FQR | |||||||||||
Myeloid/lymphoid neoplasm with PDGFRB rearrangement | Disease | Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD | FQR | |||||||||||
Myeloid/lymphoid neoplasm with FGFR1 rearrangement | Disease | Yanna Ding, MD PhD | FQR | |||||||||||
Myeloid/lymphoid neoplasm with JAK2 rearrangement | Disease | Jessica Snider, M.D. and Daynna J. Wolff, PhD | FQR | |||||||||||
Myeloid/lymphoid neoplasm with FLT3 rearrangement | Disease | FQR | ||||||||||||
Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion | Disease | FQR | ||||||||||||
Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes | Disease | FQR | ||||||||||||
Acute promyelocytic leukaemia with PML::RARA fusion | Disease | Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. | Jennelle Hodge (JH)/ Malini Sathanoori (MS) | |||||||||||
Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion | Disease | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
JH_MS | |||||||||||
Acute myeloid leukaemia with CBFB::MYH11 fusion | Disease | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
JH_MS | |||||||||||
Acute myeloid leukaemia with DEK::NUP214 fusion | Disease | JH_MS | ||||||||||||
Acute myeloid leukaemia with RBM15::MRTFA fusion | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | |||||||||||
Acute myeloid leukaemia with BCR::ABL1 fusion | Disease | Kay Weng Choy MBBS, Monash Medical Centre | JH_MS | |||||||||||
Acute myeloid leukaemia with KMT2A rearrangement | Disease | Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. | JH_MS | |||||||||||
Acute myeloid leukaemia with MECOM rearrangement | Disease | JH_MS | ||||||||||||
Acute myeloid leukaemia with NUP98 rearrangement | Disease | JH_MS | ||||||||||||
Acute myeloid leukaemia with NPM1 mutation | Disease | Xinjie Xu, PhD, FACMG | JH_MS | |||||||||||
Acute myeloid leukaemia with CEBPA mutation | Disease | Paul Defazio, MSc, Monash Health | JH_MS | |||||||||||
Acute myeloid leukaemia, myelodysplasia-related | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | |||||||||||
Acute myeloid leukaemia with other defined genetic alterations | Disease | JH_MS | ||||||||||||
Acute myeloid leukaemia with minimal differentiation | Disease | Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | JH_MS | |||||||||||
Acute myeloid leukaemia without maturation | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | |||||||||||
Acute myeloid leukaemia with maturation | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | |||||||||||
Acute basophilic leukaemia | Disease | Ashwini Yenamandra PhD FACMG | JH_MS | |||||||||||
Acute myelomonocytic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | |||||||||||
Acute monocytic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | |||||||||||
Acute erythroid leukaemia | Disease | Ashwini Yenamandra PhD FACMG | JH_MS | |||||||||||
Acute megakaryoblastic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | |||||||||||
Myeloid sarcoma | Disease | Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | JH_MS | |||||||||||
Myeloid neoplasm post cytotoxic therapy | Disease | Shawn A. Silver, DO, Shashi Shetty, Ph.D. | JH_MS | |||||||||||
Myeloid neoplasms associated with germline predisposition | Disease | JH_MS | ||||||||||||
Myeloid proliferations associated with Down syndrome | Disease | Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | JH_MS | |||||||||||
Mixed-phenotype acute leukaemia with BCR::ABL1 fusion | Disease | Tracy Tucker, PhD, FCCMG | JH_MS | |||||||||||
Mixed-phenotype acute leukaemia with KMT2A rearrangement | Disease | Tracy Tucker, PhD, FCCMG | JH_MS | |||||||||||
Acute leukaemia of ambiguous lineage with other defined genetic alterations | Disease | JH_MS | ||||||||||||
Mixed-phenotype acute leukaemia, B/myeloid | Disease | Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | JH_MS | |||||||||||
Mixed-phenotype acute leukaemia, T/myeloid | Disease | Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | JH_MS | |||||||||||
Mixed-phenotype acute leukaemia, rare types | Disease | Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | JH_MS | |||||||||||
Acute leukaemia of ambiguous lineage, NOS | Disease | JH_MS | ||||||||||||
Acute undifferentiated leukaemia | Disease | Amelia Nakanishi, MD and Shashi Shetty, PhD | JH_MS | |||||||||||
CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) |
|
|
||||||||||||
Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm | Disease | Greg Corboy (GC) | ||||||||||||
Blastic plasmacytoid dendritic cell neoplasm | Disease | Hao Liu, MD and Daynna J. Wolff, PhD | GC | |||||||||||
Langerhans cell histiocytosis | Disease | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | GC | |||||||||||
Langerhans cell sarcoma | Disease | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | GC | |||||||||||
Indeterminate dendritic cell tumour | Disease | GC | ||||||||||||
Interdigitating dendritic cell sarcoma | Disease | GC | ||||||||||||
Juvenile xanthogranuloma | Disease | GC | ||||||||||||
Erdheim-Chester disease | Disease | GC | ||||||||||||
Rosai-Dorfman Disease | Disease | GC | ||||||||||||
ALK-positive histiocytosis | Disease | GC | ||||||||||||
Histiocytic sarcoma | Disease | Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic | GC | |||||||||||
CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
||||||||||||
Reactive B-cell rich lymphoid proliferations that can mimic lymphoma | Disease | GC | ||||||||||||
IgG4-related disease | Disease | GC | ||||||||||||
Unicentric Castleman disease | Disease | GC | ||||||||||||
Idiopathic multicentric Castleman disease | Disease | GC | ||||||||||||
KSHV/HHV8-associated multicentric Castleman disease | Disease | Sudha Arumugam, MD | GC | |||||||||||
B-lymphoblastic leukaemia/lymphoma | Disease | Holli Drendel (HD) | ||||||||||||
B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy | Disease | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | HD | |||||||||||
B-lymphoblastic leukaemia/lymphoma with hypodiploidy | Disease | Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG | HD | |||||||||||
B-lymphoblastic leukaemia/lymphoma with iAMP21 | Disease | Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte | HD | |||||||||||
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion | Disease | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | HD | |||||||||||
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features | Disease | Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine | HD | |||||||||||
B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement | Disease | Yassmine Akkari Nicolas Millan | HD | |||||||||||
B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | Disease | Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma | HD | |||||||||||
B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features | Disease | HD | ||||||||||||
B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion | Disease | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | HD | |||||||||||
B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion | Disease | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | HD | |||||||||||
B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion | Disease | HD | ||||||||||||
B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations | Disease | HD | ||||||||||||
B-lymphoblastic leukaemia/lymphoma, NOS | Disease | HD | ||||||||||||
Monoclonal B-cell lymphocytosis | Disease | Shivani Golem (SG) | ||||||||||||
Chronic lymphocytic leukaemia/small lymphocytic lymphoma | Disease | Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD | SG | |||||||||||
Hairy cell leukaemia | Disease | *Snehal Patel, MD, PhD | SG | |||||||||||
Splenic marginal zone lymphoma | Disease | *Snehal Patel, MD, PhD | SG | |||||||||||
Splenic diffuse red pulp small B-cell lymphoma | Disease | *Snehal Patel, MD, PhD | SG | |||||||||||
Splenic B-cell lymphoma/leukaemia with prominent nucleoli | Disease | *Snehal Patel, MD, PhD | SG | |||||||||||
Lymphoplasmacytic lymphoma | Disease | Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | SG | |||||||||||
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | Disease | SG | ||||||||||||
Primary cutaneous marginal zone lymphoma | Disease | SG | ||||||||||||
Nodal marginal zone lymphoma | Disease | Andrew Ly, DO and Shivani Golem, PhD, FACMG | SG | |||||||||||
Paediatric nodal marginal zone lymphoma | Disease | * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | SG | |||||||||||
In situ follicular B-cell neoplasm | Disease | Rachel D. Burnside, PhD, MBA, FACMGG | SG | |||||||||||
Follicular lymphoma | Disease | Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida | SG | |||||||||||
Paediatric-type follicular lymphoma | Disease | *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG | SG | |||||||||||
Duodenal-type follicular lymphoma | Disease | SG | ||||||||||||
Primary cutaneous follicle centre lymphoma | Disease | Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG | SG | |||||||||||
In situ mantle cell neoplasm | Disease | Rina Kansal, MD; Versiti Blood Center of Wisconsin | SG | |||||||||||
Mantle cell lymphoma | Disease | * Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | SG | |||||||||||
Leukaemic non-nodal mantle cell lymphoma | Disease | SG | ||||||||||||
Transformations of indolent B-cell lymphomas | Disease | SG | ||||||||||||
Diffuse large B-cell lymphoma, NOS | Disease | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | GC | |||||||||||
T-cell/histiocyte-rich large B-cell lymphoma | Disease | GC | ||||||||||||
Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements | Disease | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | GC | |||||||||||
ALK-positive large B-cell lymphoma | Disease | Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine) | GC | |||||||||||
Large B-cell lymphoma with IRF4 rearrangement | Disease | *Afia Hasnain, MBBS, PhD | GC | |||||||||||
High grade B-cell lymphoma with 11q aberrations | Disease | Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | GC | |||||||||||
Lymphomatoid granulomatosis | Disease | GC | ||||||||||||
EBV-positive diffuse large B-cell lymphoma | Disease | GC | ||||||||||||
Diffuse large B-cell lymphoma associated with chronic inflammation | Disease | GC | ||||||||||||
Fibrin-associated large B-cell lymphoma | Disease | GC | ||||||||||||
Fluid overload-associated large B-cell lymphoma | Disease | GC | ||||||||||||
Plasmablastic lymphoma | Disease | Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | GC | |||||||||||
Primary large B-cell lymphoma of immune-privileged sites | Disease | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | GC | |||||||||||
Primary cutaneous diffuse large B-cell lymphoma, leg type | Disease | GC | ||||||||||||
Intravascular large B-cell lymphoma | Disease | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | GC | |||||||||||
Primary mediastinal large B-cell lymphoma | Disease | GC | ||||||||||||
Mediastinal grey zone lymphoma | Disease | GC | ||||||||||||
High-grade B-cell lymphoma, NOS | Disease | Aiko Otsubo, PhD, Indiana University | GC | |||||||||||
Burkitt lymphoma | Disease | Becky Leung, MBBS (Hons), BSc, Pathology Queensland | GC | |||||||||||
Primary effusion lymphoma | Disease | GC | ||||||||||||
KSHV/HHV8-positive diffuse large B-cell lymphoma | Disease | GC | ||||||||||||
KSHV/HHV8-positive germinotropic lymphoproliferative disorder | Disease | GC | ||||||||||||
Hyperplasias arising in immune deficiency/dysregulation | Disease | GC | ||||||||||||
Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation | Disease | Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) | GC | |||||||||||
EBV-positive mucocutaneous ulcer | Disease | GC | ||||||||||||
Lymphomas arising in immune deficiency / dysregulation | Disease | GC | ||||||||||||
Inborn error of immunity-associated lymphoid proliferations and lymphomas | Disease | GC | ||||||||||||
Classic Hodgkin lymphoma | Disease | Patricia V. Hernandez, M.D., Washington University School of Medicine | GC | |||||||||||
Nodular lymphocyte predominant Hodgkin lymphoma | Disease | GC | ||||||||||||
Cold agglutinin disease | Disease | SG | ||||||||||||
IgM monoclonal gammopathy of undetermined significance | Disease | SG | ||||||||||||
Non-IgM monoclonal gammopathy of undetermined significance | Disease | SG | ||||||||||||
Monoclonal gammopathy of renal significance | Disease | SG | ||||||||||||
Immunoglobulin-related (AL) amyloidosis | Disease | Heather E. Williams, PhD, MS, PgD, ErCLG | SG | |||||||||||
Monoclonal immunoglobulin deposition disease | Disease | Chen Yang, MD, PhD, University of Michigan | SG | |||||||||||
Mu heavy chain disease | Disease | SG | ||||||||||||
Gamma heavy chain disease | Disease | Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | SG | |||||||||||
Alpha heavy chain disease | Disease | SG | ||||||||||||
Plasmacytoma | Disease | SG | ||||||||||||
Plasma cell myeloma / multiple myeloma | Disease | *Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | SG | |||||||||||
Plasma cell neoplasms with associated paraneoplastic syndrome | Disease | Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD | SG | |||||||||||
CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
||||||||||||
Kikuchi-Fujimoto disease | Disease | Sumi Kitahara (SK) | ||||||||||||
Autoimmune lymphoproliferative syndrome | Disease | SK | ||||||||||||
Indolent T-lymphoblastic proliferation | Disease | SK | ||||||||||||
T-lymphoblastic leukaemia / lymphoma, NOS | Disease | HD | ||||||||||||
Early T-precursor lymphoblastic leukaemia / lymphoma | Disease | Fei Yang, MD, FACMG, Kaiser Permanente Northwest | HD | |||||||||||
T-prolymphocytic leukaemia | Disease | SK | ||||||||||||
T-large granular lymphocytic leukaemia | Disease | *Michelle Don, MD, MS | SK | |||||||||||
NK-large granular lymphocytic leukaemia | Disease | Michelle Don, MD | SK | |||||||||||
Adult T-cell leukaemia/lymphoma | Disease | Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center | SK | |||||||||||
Sezary syndrome | Disease | Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina | SK | |||||||||||
Aggressive NK-cell leukaemia | Disease | Shanelle De Lancy, MD, Shashirekha Shetty, PhD | SK | |||||||||||
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder | Disease | SK | ||||||||||||
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder | Disease | SK | ||||||||||||
Mycosis fungoides | Disease | Jane Scribner, MD and Daynna J. Wolff, PhD | SK | |||||||||||
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis | Disease | SK | ||||||||||||
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma | Disease | Theresa Spivey, MD, Shashirekha Shetty, PhD | SK | |||||||||||
Subcutaneous panniculitis-like T-cell lymphoma | Disease | SK | ||||||||||||
Primary cutaneous gamma/delta T-cell lymphoma | Disease | SK | ||||||||||||
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma | Disease | SK | ||||||||||||
Primary cutaneous peripheral T-cell lymphoma, NOS | Disease | SK | ||||||||||||
Indolent T-cell lymphoma of the gastrointestinal tract | Disease | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | SK | |||||||||||
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract | Disease | SK | ||||||||||||
Enteropathy-associated T-cell lymphoma | Disease | *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | SK | |||||||||||
Monomorphic epitheliotropic intestinal T-cell lymphoma | Disease | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | SK | |||||||||||
Intestinal T-cell lymphoma, NOS | Disease | Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA) | SK | |||||||||||
Hepatosplenic T-cell lymphoma | Disease | *Michelle Don, MD, MS | SK | |||||||||||
ALK-positive anaplastic large cell lymphoma | Disease | SK | ||||||||||||
ALK-negative anaplastic large cell lymphoma | Disease | Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA | SK | |||||||||||
Breast implant-associated anaplastic large cell lymphoma | Disease | Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center | SK | |||||||||||
Nodal TFH cell lymphoma, angioimmunoblastic-type | Disease | * Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG | SK | |||||||||||
Nodal TFH cell lymphoma, follicular-type | Disease | SK | ||||||||||||
Nodal TFH cell lymphoma, NOS | Disease | Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD | SK | |||||||||||
Peripheral T-cell lymphoma, NOS | Disease | SK | ||||||||||||
EBV-positive nodal T- and NK-cell lymphoma | Disease | SK | ||||||||||||
Extranodal NK/T-cell lymphoma | Disease | SK | ||||||||||||
Severe mosquito bite allergy | Disease | SK | ||||||||||||
Hydroa vacciniforme lymphoproliferative disorder | Disease | SK | ||||||||||||
Systemic chronic active EBV disease | Disease | SK | ||||||||||||
Systemic EBV-positive T-cell lymphoma of childhood | Disease | *Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA | SK | |||||||||||
CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES) |
|
|
||||||||||||
Follicular dendritic cell sarcoma | Disease | Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG | GC | |||||||||||
EBV-positive inflammatory follicular dendritic cell sarcoma | Disease | GC | ||||||||||||
Fibroblastic reticular cell tumour | Disease | GC | ||||||||||||
Intranodal palisaded myofibroblastoma | Disease | GC | ||||||||||||
Littoral cell angioma | Disease | GC | ||||||||||||
Splenic hamartoma | Disease | GC | ||||||||||||
Sclerosing angiomatoid nodular transformation (SANT) of spleen | Disease | GC | ||||||||||||
CHAPTER 7 (GENETIC TUMOUR SYNDROMES) |
|
|
||||||||||||
Fanconi anaemia | Disease | NA | ||||||||||||
Bloom syndrome | Disease | NA | ||||||||||||
Ataxia-telangiectasia syndrome | Disease | NA | ||||||||||||
RASopathies | Disease | NA |